Tetanustoxoid

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Antibiotics & Anti-Infectives treatment.

🧴 Clinical Application

Administered by a licensed healthcare professional by deep intramuscular (IM) injection, preferably into the deltoid muscle in adults or anterolateral thigh in infants. Never administer intravenously. Adhere to national immunization schedules and booster intervals.

⚠️ Side Effects

Common: Local tenderness, erythema, swelling, or induration at injection site; low-grade fever; mild malaise; headache. Rare/Severe: Severe anaphylaxis, Guillain-Barré syndrome, brachial neuritis, and sterile abscess at injection site.

🛡️ Safety Warnings

Contraindicated in patients with severe acute hypersensitivity to previous doses. In patients with bleeding disorders, administer with caution to avoid hematoma. If a wound is tetanus-prone and high risk, tetanus immunoglobulin (TIG) should be administered concomitantly at a separate anatomical site.